Company Overview and News

 
7 Retirement Stocks for the 30-and-Under Crowd

9m investorplace
When it comes to retirement strategy, most experts counsel some form of buy and hold investing. But there’s a catch: buy and hold investing can be quite difficult.
Upvote Downvote

 
Amazon.com, Inc. Is Changing How the Military Shops

11h investorplace
Companies spend millions up-front trying to win contracts. The process can take years. The result is usually a draw, with the same set of companies divvying up the spoils. To get their marketing dollars out, you get the $640 toilet seat.
Upvote Downvote

 
Pivotal IPO: 5 things to know about the cloud software company - MarketWatch

12h marketwatch
Cloud software has been a hot sector for initial public offerings, but now we will see how Wall Street feels about cloud software used to make more cloud software.
Upvote Downvote

 
It's easy to copy Warren Buffett buying Berkshire Hathaway's holdings

2018-04-19 valuewalkpremium
Warren Buffett is considered to be the greatest investor of all time. And he is one of the most talked about investors, with financial publications always offering news and views on his interviews and stock positions.
Upvote Downvote

1
A Tech Giant No More: IBM Is Too Small to Compete in the Cloud Era | InvestorPlace

2018-04-19 investorplace
Caught between obligations to shareholders and employees, IBM (NYSE:IBM) was unable to commit to the $1 billion per quarter needed to compete in cloud early in this decade. It is now paying the price.
Upvote Downvote

 
Why is Oracle (ORCL) Down 11.4% Since its Last Earnings Report?

2018-04-18 zacks
A month has gone by since the last earnings report for Oracle Corporation (ORCL - Free Report) . Shares have lost about 11.4% in that time frame.
Upvote Downvote

 
Pentagon revises request for cloud computing services

2018-04-16 channelnewsasia
WASHINGTON: The U.S. Department of Defense on Monday updated its request for proposals from potential bidders on a US$10 billion project for cloud computing services, in a deal that has been closely watched because Amazon.com Inc has been considered to be a top contender.
Upvote Downvote

 
Pentagon revises request for cloud computing services

2018-04-16 reuters
WASHINGTON (Reuters) - The U.S. Department of Defense on Monday updated its request for proposals from potential bidders on a $10 billion project for cloud computing services, in a deal that has been closely watched because Amazon.com Inc (AMZN.O) has been considered to be a top contender.
Upvote Downvote

 
The Bull Case Keeps Getting Better for Cisco Systems, Inc. Stock

2018-04-16 investorplace
During the past few months, Cisco Systems, Inc. (NASDAQ:CSCO) certainly has been volatile, a has much of the tech sector. Just take a look at the charts for big-names like Facebook, Inc. (NASDAQ:FB), Amazon.com, Inc. (NASDAQ:AMZN) and Oracle Corporation (NYSE:ORCL). Yet Cisco stock has still been able to manage through all this fairly well.
Upvote Downvote

 
Oracle co-CEO Catz expects acceleration in cloud business - Channel NewsAsia

2018-04-16 channelnewsasia
Oracle Corp co-CEO Safra Catz said on Monday she expected an acceleration in the company's cloud business after the software maker last month reported sales from this business that fell short of Wall Street forecasts.
Upvote Downvote

 
UPDATE 1-Oracle co-CEO Catz expects acceleration in cloud business

2018-04-16 reuters
TEL AVIV, April 16 (Reuters) - Oracle Corp co-CEO Safra Catz said on Monday she expected an acceleration in the company’s cloud business after the software maker last month reported sales from this business that fell short of Wall Street forecasts.
Upvote Downvote

 
Oracle Co-CEO Tells Trump Pentagon Cloud Plan Makes ‘No Sense’ - Bloomberg

2018-04-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Oracle co-CEO Catz expects acceleration in cloud business

2018-04-16 reuters
TEL AVIV (Reuters) - Oracle Corp co-CEO Safra Catz said on Monday she expects an acceleration in the company’s cloud business after the software maker last month reported sales from its cloud business that fell short of Wall Street expectations.
Upvote Downvote

 
Oracle's Customer Experience Cloud Suite Expands Offerings

2018-04-12 zacks
Oracle Corporation (ORCL - Free Report) is slowly and steadily expanding its foothold in the cloud and enterprise Artificial Intelligence (AI) market. The company recently unveiled new additions to Oracle Customer Experience (“CX”) Cloud Suite namely Oracle Infinity and Oracle CX Audience. It also launched Oracle Loyalty.
Upvote Downvote

 
Apple is the most valuable company on the world but has a billionaire shortage

2018-04-11 theage.com.au
Finding billionaires in Silicon Valley isn't hard. Dropbox's Arash Ferdowsi and Veeva Systems Inc.'s Peter Gassner have both crossed the threshold this year, and tech fortunes make up a fifth - or about $US1 trillion ($1.3 trillion) - of the Bloomberg Billionaires Index.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...